AbbVie
ABBV
$1.24 (-0.56%)
1D
1W
3M
1Y
5Y
ALL
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
24/7 Wall Street • 9 hours ago • ABBV
3 Dividend Stocks That Pay You More Every Single Year
Zacks Investment Research • 1 day ago • ABBV
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Seeking Alpha • 1 day ago • ABBV
AbbVie: Maintaining My Strong Buy Rating After Label Expansion
24/7 Wall Street • 1 day ago • ABBV
This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie
24/7 Wall Street • 1 day ago • ABBV
AbbVie Stock Will Hit $300 on This Date
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.